Molecular mechanisms underlying NEPC development involve dysregulation of various signaling pathways, including MYCN, RB1, and TP53, leading to neuroendocrine trans differentiation and aggressive tumor behavior [59]. The gene discussed is TP53; the disease is neoplasm.